Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment
June 24, 2024 updated by: NOCD
Effectiveness of Video Teletherapy in Treating Child and Adolescent Obsessive-Compulsive Disorder With Exposure and Response Prevention: a Retrospective Longitudinal Observational Study
This is a naturalistic, observational study of children and adolescents with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
2173
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60601
- NOCD, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This is a naturalistic sample of children and adolescents obsessive-compulsive disorder (OCD) who sought treatment for OCD from NOCD, Inc., a digital behavioral health company.
Description
Inclusion Criteria:
- obsessive-compulsive disorder
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Obsessive-Compulsive Disorder
adolescents and children with obsessive-compulsive disorder
|
Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by therapists remotely via video.
The treatment was augmented by between-session text messaging.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dimensional Obsessive-Compulsive Scale
Time Frame: change from pre-treatment to post-treatment (after 11 weeks)
|
self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes (score range: 0-80)
|
change from pre-treatment to post-treatment (after 11 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression Anxiety and Stress Scale (DASS-21)
Time Frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
|
self-rated psychometric instrument to measure depression, anxiety, and stress (score range: 0-63)
|
pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 23, 2020
Primary Completion (Actual)
May 3, 2024
Study Completion (Actual)
May 3, 2024
Study Registration Dates
First Submitted
June 14, 2024
First Submitted That Met QC Criteria
June 14, 2024
First Posted (Actual)
June 20, 2024
Study Record Updates
Last Update Posted (Actual)
June 26, 2024
Last Update Submitted That Met QC Criteria
June 24, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NOCD002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.